Screening, inclusion visit and randomization
All patients aged ≥ 65 years old admitted to hospital for MI and undergoing treatment of any coronary lesion considered suitable for revascularization will be provided information about the study protocol, aims, risks and benefits. MI diagnosis will be based on symptoms, electrocardiographic changes and rise and fall in cardiac biomarker (cardiac troponin), in agreement with current guidelines [Description and interpretation of SPPB scale. 